Therefore, targeting acid ceramidase 1 and glucocerebrosidase 2, which regulate the production and metabolism of glucosylsphingosine, holds a promising prospect for the treatment of mutant GBA-associated PD. This evidence concerns the gene GBA1 and Parkinson disease.